Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer

We are reporting a case of multifocal reversible leucoencephalopathy syndrome induced by chemotherapy based on Folfox-Bevacizumab regimen. A 44-year-old female, with no history of hypertension, received a chemotherapy based on Folfox-Bevacizumab for her metastatic colon cancer (5 FU: 325 mg/m(2) d1...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmi, Narimane, Elghissassi, Ibrahim, Bellahammou, Khadija, Lakhdissi, Asmaa, Mrabti, Hind, Errihani, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221973/
https://www.ncbi.nlm.nih.gov/pubmed/25400959
http://dx.doi.org/10.1155/2014/391256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221973/
https://www.ncbi.nlm.nih.gov/pubmed/25400959
http://dx.doi.org/10.1155/2014/391256

Ejemplares similares